Cargando…

Evidence for an effect of ACE inhibitors on cancer cachexia

Detalles Bibliográficos
Autores principales:	Schanze, Nancy, Springer, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374020/ https://www.ncbi.nlm.nih.gov/pubmed/22639062 http://dx.doi.org/10.1007/s13539-012-0072-8

Ejemplares similares

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?
por: Ishida, Junichi, et al.
Publicado: (2017)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Tschirner, Anika, et al.
Publicado: (2012)

The Effect of ACE Inhibitor on the Quality of Life amongst Patients with Cancer Cachexia
por: Dehghani, Mehdi, et al.
Publicado: (2020)

Open source in cachexia?
por: Stemmler, Britta, et al.
Publicado: (2015)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

Comment on 'Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer' by Xie et al.
por: Ding, Ping'an, et al.
Publicado: (2023)

Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management
por: Kumar, Nagi B.
Publicado: (2021)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Biomarkers for cancer cachexia: where do we stand?
por: Palus, Sandra, et al.
Publicado: (2020)

Identification of Cause of Posttransplant Cachexia by PCR
por: Guitard, Joelle, et al.
Publicado: (2012)

An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations
por: Wild, Philipp S., et al.
Publicado: (2020)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Cardiac Cachexia - A Window to the Wasting Disorders
por: Coats, Andrew J Stewart
Publicado: (2018)

Biomarkers and mechanisms associated with cancer‐induced cardiac cachexia: A systematic review
por: Bagnall, Lisa, et al.
Publicado: (2023)

Lipolysis by pancreatic cancer‐derived extracellular vesicles in cancer‐associated cachexia via specific integrins
por: Shibata, Chikako, et al.
Publicado: (2022)

Comment on ‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.
por: Xie, Longxiang, et al.
Publicado: (2021)

Comment on ‘The expression landscape of cachexia‐inducing factors in human cancers’ by Freire et al.
por: Song, Shiyu, et al.
Publicado: (2020)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Anti‐cachexia therapy should target metabolism, inflammatory cytokines, and androgens in hormone‐independent cancers
por: Lambert, Charles Paul
Publicado: (2021)

Formoterol in the treatment of experimental cancer cachexia: effects on heart function
por: Toledo, Míriam, et al.
Publicado: (2014)

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
por: Wu, Qi, et al.
Publicado: (2018)

Cardiac cachexia: hic et nunc
por: Loncar, Goran, et al.
Publicado: (2016)

Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
por: Gharebaghi, Reza, et al.
Publicado: (2022)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

ACE inhibitor-related angioedema in a COVID-19 patient—a plausible contribution of the viral infection?
por: Kuzemczak, Michał, et al.
Publicado: (2021)

Response Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
por: Shakhsi-Niaei, Mostafa, et al.
Publicado: (2022)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?
por: Ishida, Junichi, et al.
Publicado: (2017)

Nutrition in cachexia: from bench to bedside
por: Konishi, Masaaki, et al.
Publicado: (2016)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Induction of cachexia in mice
por: Tisdale, M
Publicado: (1999)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients
por: Saitoh, Masakazu, et al.
Publicado: (2016)

Comment on ‘COVID‐19: a major cause of cachexia and sarcopenia’ by Morley et al.
por: Zhou, Ling, et al.
Publicado: (2020)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
por: Ishida, Junichi, et al.
Publicado: (2015)

ACE polymorphism and COVID-19 outcome
por: Delanghe, Joris R., et al.
Publicado: (2020)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients
por: Ishida, Junichi, et al.
Publicado: (2016)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
por: Thum, Thomas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_prff80ofsu0kf75hbs6acv25hn